These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12654419)

  • 21. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel use of ViewRay MRI guidance for high-dose-rate brachytherapy in the treatment of cervical cancer.
    Ko HC; Huang JY; Miller JR; Das RK; Wallace CR; De Costa AA; Francis DM; Straub MR; Anderson BM; Bradley KA
    Brachytherapy; 2018; 17(4):680-688. PubMed ID: 29773331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulsed low dose rate brachytherapy for pelvic malignancies.
    Swift PS; Purser P; Roberts LW; Pickett B; Powell CB; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):811-7. PubMed ID: 9128956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer.
    Lee YC; Rash DL; Stern RL; Mayadev JS
    Brachytherapy; 2013; 12(6):555-9. PubMed ID: 23880417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of the effectiveness of radiation treatment for cervical cancer].
    Turkevich VG
    Vopr Onkol; 2014; 60(3):366-70. PubMed ID: 25033692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moving toward uniform and evidence-based practice of radiotherapy for management of cervical cancer in Ontario, Canada.
    Shahid N; Craig T; Westerland M; Ashworth A; Ang M; D'Souza D; Sankreacha R; Fyles A; Milosevic M; Kong I;
    Brachytherapy; 2018; 17(4):660-666. PubMed ID: 29681500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose-rate brachytherapy for cervical carcinoma.
    Stitt JA; Thomadsen BR; Fowler JF
    Int J Radiat Oncol Biol Phys; 1992; 24(3):574. PubMed ID: 1489449
    [No Abstract]   [Full Text] [Related]  

  • 31. Cervix cancer brachytherapy: high dose rate.
    Miglierini P; Malhaire JP; Goasduff G; Miranda O; Pradier O
    Cancer Radiother; 2014 Oct; 18(5-6):452-7. PubMed ID: 25151650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of RTOG 88-05: twice-daily external irradiation with brachytherapy for carcinoma of the cervix.
    Grigsby P; Winter K; Komaki R; Marcial V; Eifel P; Doncals D; Stevens R; Rotman M; Gaffney D
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):51-7. PubMed ID: 12182974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
    Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [High dose brachytherapy in gynecologic neoplasms. Review of the literature].
    Portaluri M; Raguso A; Parisi S; Paleani Vettori PG
    Minerva Ginecol; 1991 Mar; 43(3):87-95. PubMed ID: 2057107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer.
    Stewart AJ; Viswanathan AN
    Cancer; 2006 Sep; 107(5):908-15. PubMed ID: 16874815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary results of a comparison between high-tech external beam and high-tech brachytherapy for cervix carcinoma.
    Georg D; Kirisits C; Hillbrand M; Dimopoulos J; Pötter R
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():19-20. PubMed ID: 18167001
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous modulated accelerated radiotherapy in cervical cancer with retroperitoneal lymph node metastasis after radical hysterectomy and pelvic lymphadenectomy.
    Li XL; Chen ZY; Cui YC; Sheng XG
    Int J Gynecol Cancer; 2015 Jun; 25(5):903-9. PubMed ID: 25822099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
    Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
    Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose rate interstitial brachytherapy using two weekly sessions of 10 Gy each for patients with locally advanced cervical carcinoma.
    Sharma DN; Rath GK; Thulkar S; Kumar S; Subramani V; Julka PK
    Brachytherapy; 2011; 10(3):242-8. PubMed ID: 20932811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.